Enliven Therapeutics, Inc. ELVN
50.52 USD -1.03 (-2.00%)
Nov 10, 2026, 12:28 PM EST
49.74 Day range 51.35
14.79 52-week range 62.32
- YTD
- +228.05%
- 1 year
- +170.02%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 616.00K | 637.00K | 603.00K | 215.00K | 99.00K | |
| 218.87M | 133.16M | 234.29M | -1.80M | 49.10M | |
| -25.27M | 23.98M | 24.61M | -34.49M | 698.00K | |
| 55.00K | -44.00K | -149.00K | -612.00K | -12.00K | |
| 219.08M | 133.16M | 161.76M | 591.00K | 49.68M | |
| -173.84M | -36.00M | -148.41M | -612.00K | -1.63M | |
| -173.90M | -36.83M | -148.26M | 0 | -1.62M | |
| -70.30M | -73.19M | -61.27M | -32.08M | -46.77M | |
| 34.02M | 20.17M | 12.91M | 3.19M | 3.85M |